Skaana Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-79,406
Closed -$39.7K 165
2022
Q4
$39.7K Sell
79,406
-17,261
-18% -$11K 0.01% 119
2022
Q3
$62K Sell
96,667
-7,500
-7% -$6.36K 0.02% 59
2022
Q2
$70K Sell
104,167
-11,289
-10% -$17.1K 0.02% 68
2022
Q1
$234K Sell
115,456
-39,947
-26% -$62.8K 0.04% 70
2021
Q4
$343K Buy
+155,403
New +$380K 0.05% 105

Other funds holding SRTAW

Skaana Management's SRTAW Position: Q1 2023 in Review

Skaana Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2023, closing a stake of 79,406 shares — an estimated $39.7K sold.

Skaana Management first reported a position in SRTAW in Q4 2021 and held it in 5 quarters. The position peaked at $343K in Q4 2021. 11 funds tracked by Wall St. Rank hold SRTAW as of Q1 2023.

  • Skaana Management reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2023 after selling out during the quarter.
  • Skaana Management sold 79,406 Strata Critical Medical Inc Warrants shares in Q1 2023, an estimated $39.7K.
  • Skaana Management first reported a position in Strata Critical Medical Inc Warrants in Q4 2021 and held it in 5 quarters.
  • Skaana Management's Strata Critical Medical Inc Warrants position peaked at $343K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2023.

Based on Skaana Management's 13F filing for Q1 2023, filed 15 May 2023.